| scholarly article | Q13442814 |
| review article | Q7318358 |
| P356 | DOI | 10.1016/0163-7258(90)90042-Z |
| P698 | PubMed publication ID | 2195551 |
| P2093 | author name string | Bertino JR | |
| Rustum YM | |||
| Mini E | |||
| Trave F | |||
| P433 | issue | 1 | |
| P921 | main subject | fluorouracil | Q238512 |
| P304 | page(s) | 1-19 | |
| P577 | publication date | 1990-01-01 | |
| P1433 | published in | Pharmacology & Therapeutics | Q3378596 |
| P1476 | title | Enhancement of the antitumor effects of 5-fluorouracil by folinic acid | |
| P478 | volume | 47 |
| Q43573396 | 5-Fluorouracil induced Fas upregulation associated with apoptosis in liver metastases of colorectal cancer patients |
| Q67831587 | A sensitive radioenzymatic assay for (S)-5-formyltetrahydrofolate |
| Q33919546 | Basis for effective combination cancer chemotherapy with antimetabolites |
| Q46231667 | Bimonthly chemotherapy with oxaliplatin, irinotecan, infusional 5-fluorouracil/folinic acid in patients with metastatic colorectal cancer pretreated with irinotecan- or oxaliplatin-based chemotherapy |
| Q67541455 | Biochemical modulation of 5-fluorouracil with or without leucovorin by a low dose of brequinar in MGH-U1 cells |
| Q37855365 | Biochemical modulation of fluoropyrimidines by antifolates and folates in an in vitro model of human leukemia |
| Q36705141 | Biochemical pharmacology and analysis of fluoropyrimidines alone and in combination with modulators |
| Q53527669 | Combined radiotherapy and chemotherapy (cisplatin and 5-fluorouracil) as palliative treatment for localized unresectable or adjuvant treatment for resected pancreatic adenocarcinoma: results of a feasibility study. |
| Q46612816 | Fluorouracil plus leucovorin induces submandibular salivary gland enlargement in rats |
| Q52828371 | Folate depletion increases sensitivity of solid tumor cell lines to 5-fluorouracil and antifolates. |
| Q42439192 | Impact of schedule on leucovorin potentiation of fluorouracil antitumor activity in dietary folic acid deplete mice. |
| Q27026129 | Management of locally advanced and metastatic colon cancer in elderly patients |
| Q36639785 | Metabolism and mechanism of action of 5-fluorouracil |
| Q44569042 | Methionine restriction selectively targets thymidylate synthase in prostate cancer cells. |
| Q28370889 | Modulation of fluorouracil antitumor activity by folic acid in a murine model system |
| Q34107734 | Novel chemotherapy agents for colorectal cancer: oral fluoropyrimidines, oxaliplatin, and raltitrexed |
| Q34107768 | Novel oral chemotherapy agents |
| Q37430384 | Pharmacogenetics: implementing personalized medicine |
| Q42691338 | Pharmacogenomics DNA Biomarkers in Colorectal Cancer: Current Update |
| Q67842100 | Preparation of a chiral matrix. Resolution of (6R,S)-N5-formyltetrahydrofolate |
| Q36028631 | Prospective clinical trials using a pharmacogenetic/pharmacogenomic approach |
| Q43695188 | Rb, mcl-1 and p53 expression correlate with clinical outcome in patients with liver metastases from colorectal cancer |
| Q45950927 | Regulation of T cell proliferation with drug-responsive microRNA switches. |
| Q27021105 | Review of systemic therapies for locally advanced and metastatic rectal cancer |
| Q45038133 | Surgical therapy of liver metastases. Therapeutic procedures, results and prognostic factors |
| Q72875665 | The pharmacokinetics of reduced folates after intraperitoneal and intravenous administration of racemic [6S,R]-folinic acid |
| Q40423844 | Thymidylate synthase and drug resistance |
| Q53579494 | Treatment of patients with advanced gastric carcinoma with a 5-fluorouracil-based or a cisplatin-based regimen: two parallel randomized phase II studies. |
Search more.